Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
49
LXEO Quote, Financials, Valuation and Earnings
Last price:
$9.49
Seasonality move
:
-53.42%
Day range:
$9.11 - $9.45
52-week range:
$1.45 - $10.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.57x
Volume:
920.7K
Avg. volume:
1.3M
1-year change:
32.06%
Market cap:
$310.3M
Revenue:
--
EPS (TTM):
-$2.70
Earnings Data
Next earnings date for LXEO
Mar 23
2026
Most recent earnings per share
-$0.33
Beat by $0.13
(Nov 5/2025)
Consensus Estimate
-$0.46
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LXEO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/23/2026 | Q4 | -- | -- | -- | -$0.31 | -- |
| 11/05/2025 | Q3 | -- | -- | -$0.33 | -$0.46 | $0.13 |
| 08/14/2025 | Q2 | -- | -- | -$0.60 | -$0.66 | $0.06 |
| 05/08/2025 | Q1 | -- | -- | -$0.99 | -$0.77 | -$0.21 |
| 03/24/2025 | Q4 | -- | -- | -$0.78 | -$0.78 | -$0.01 |
| 11/13/2024 | Q3 | -- | -- | -$0.89 | -$0.67 | -$0.22 |
| 08/12/2024 | Q2 | -- | -- | -$0.64 | -$0.69 | $0.05 |
| 05/09/2024 | Q1 | -- | -- | -$0.77 | -$0.79 | $0.02 |
| 03/11/2024 | Q4 | -- | -- | -$0.53 | -$0.75 | $0.22 |
| 12/11/2023 | Q3 | -- | -- | -$0.75 | -$3.02 | $2.26 |
| 06/30/2023 | Q2 | -- | -- | -$0.50 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.70 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.58 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.68 | -- | -- |
| 06/30/2022 | Q2 | -- | $37K | -$0.57 | -- | -- |
| 03/31/2022 | Q1 | -- | $85.6K | -$0.47 | -- | -- |
Lexeo Therapeutics, Inc. Earnings Questions
-
How Much did Lexeo Therapeutics, Inc. Generate in Revenue Last Quarter?
Lexeo Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Lexeo Therapeutics, Inc. Beat Earnings Last Quarter?
Lexeo Therapeutics, Inc. announced earnings per share of -$0.33 which represents a beat of analyst forecast a -$0.46 per share.
-
Is Lexeo Therapeutics, Inc. Profitable?
Lexeo Therapeutics, Inc. reported -$530K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Lexeo Therapeutics, Inc. EPS Next Year?
Lexeo Therapeutics, Inc.'s earnings are forecast to decrease from -$3.09 per share to -$3.09 per share next year representing a decrease of -37.47%.
-
When is Lexeo Therapeutics, Inc.'s Earnings Date?
Lexeo Therapeutics, Inc.'s next earnings date is March 23, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 65.44% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.33% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.85% over the past day.
